![]()
Distribution 2289 closing date 14-APR-2008
Weighed-in concentrations and
All-laboratory Trimmed Means (
|
Analyte |
Weighed-in (mg/L) |
Target* |
(mg/L) |
Returns |
SD |
CV% |
|
Amikacin |
20.0 |
|
20.1 |
100 |
1.01 |
5.03 |
|
Flucytosine |
33.0 |
NS |
30.3 |
9 |
3.53 |
11.66 |
|
Gentamicin |
12.3 |
|
11 |
251 |
1.17 |
10.6 |
|
Netilmicin |
16.1 |
NS |
15.1 |
8 |
1.43 |
9.47 |
|
Teicoplanin |
41.2 |
|
43 |
25 |
4.16 |
9.68 |
|
Tobramycin |
3.5 |
|
3.5 |
121 |
0.29 |
8.4 |
|
Vancomycin |
|
|
24.7 |
254 |
2.02 |
8.16 |
Distribution 2290 closing date
Weighed-in
concentrations and All-laboratory Trimmed Means (
|
Analyte |
Weighed-in (mg/L) |
Target* |
(mg/L) |
Returns |
SD |
CV% |
|
Amikacin |
2.5 |
NS |
2.7 |
97 |
0.38 |
14.2 |
|
Flucytosine |
80.0 |
NS |
78.0 |
8 |
7.57 |
9.71 |
|
Gentamicin |
7.9 |
|
7.2 |
253 |
0.48 |
6.65 |
|
Netilmicin |
4.0 |
NS |
4.0 |
6 |
0.81 |
20.06 |
|
Teicoplanin |
13.6 |
|
14.3 |
25 |
1.03 |
7.23 |
|
Tobramycin |
12.2 |
|
12.4 |
117 |
1.4 |
11.30 |
|
Vancomycin |
23.5 |
|
22.8 |
253 |
1.88 |
8.25 |
|
*NS means the analyte was not scored |
|
|||||
Distribution 2291 closing date
Weighed-in
concentrations and All-laboratory Trimmed Means (
|
Analyte |
Weighed-in (mg/L) |
Target* |
(mg/L) |
Returns |
SD |
CV% |
|
Amikacin |
25.0 |
|
22.2 |
98 |
1.2 |
5.4 |
|
Flucytosine |
71.0 |
NS |
67.6 |
7 |
7.6 |
11.2 |
|
Gentamicin |
1.4 |
|
1.3 |
255 |
0.2 |
13.2 |
|
Netilmicin |
13.7 |
NS |
12.6 |
6 |
4.6 |
36.5 |
|
Teicoplanin |
61.2 |
|
59.7 |
23 |
3.9 |
6.6 |
|
Tobramycin |
9.0 |
|
9.4 |
118 |
0.9 |
9.3 |
|
Vancomycin |
60.0 |
|
59.4 |
254 |
5.8 |
9.7 |
|
*NS means the analyte was not scored |
|
|||||
Distribution 2292 closing date
Weighed-in
concentrations and All-laboratory Trimmed Means (
|
Analyte |
Weighed-in (mg/L) |
Target* |
(mg/L) |
Returns |
SD |
CV% |
|
Amikacin |
15.6 |
|
14.4 |
97 |
1.0 |
6.6 |
|
Flucytosine |
118.0 |
NS |
109.4 |
8 |
17.1 |
15.7 |
|
Gentamicin |
10.5 |
|
9.3 |
247 |
0.8 |
8.3 |
|
Netilmicin |
7.5 |
NS |
7.8 |
6 |
1.7 |
21.9 |
|
Teicoplanin |
18.9 |
|
19.2 |
25 |
1.5 |
7.6 |
|
Tobramycin |
1.8 |
|
1.9 |
116 |
0.2 |
9.3 |
|
Vancomycin |
15.1 |
|
15.4 |
251 |
1.2 |
7.1 |
|
*NS means the analyte was not scored |
|
|||||
Distribution 2293 closing date
Weighed-in
concentrations and All-laboratory Trimmed Means (
|
Analyte |
Weighed-in (mg/L) |
Target* |
(mg/L) |
Returns |
SD |
CV% |
|
Amikacin |
57.0 |
|
50.7 |
95 |
4.1 |
8.1 |
|
Flucytosine |
51.0 |
NS |
48.6 |
9 |
6.7 |
13.8 |
|
Gentamicin |
6.7 |
|
6.2 |
256 |
0.6 |
9.6 |
|
Netilmicin |
2.4 |
NS |
2.6 |
4 |
0.4 |
16.0 |
|
Teicoplanin |
3.0 |
NS |
2.9 |
22 |
0.7 |
25.5 |
|
Tobramycin |
10.1 |
|
10.5 |
115 |
1.0 |
9.9 |
|
Vancomycin |
44 |
|
43.7 |
253 |
3.5 |
8.0 |
Distribution 2294 closing date
Weighed-in concentrations and
All-laboratory Trimmed Means (
|
Analyte |
Weighed-in (mg/L) |
Target* |
(mg/L) |
Returns |
SD |
CV% |
|
Amikacin |
13.8 |
|
12.7 |
96 |
0.8 |
6.1 |
|
Flucytosine |
92.0 |
NS |
72.0 |
8 |
21.1 |
29.3 |
|
Gentamicin |
15.4 |
|
14.3 |
238 |
1.2 |
8.2 |
|
Netilmicin |
11.3 |
NS |
10.2 |
5 |
1.0 |
9.5 |
|
Teicoplanin |
45.6 |
|
45.5 |
24 |
3.6 |
7.8 |
|
Tobramycin |
6.4 |
|
6.5 |
116 |
0.5 |
8.1 |
|
Vancomycin |
28.6 |
|
28.8 |
250 |
2.3 |
8.0 |
|
*NS means the analyte was not scored |
|
|||||
Distribution 2295 closing date
Weighed-in concentrations and
All-laboratory Trimmed Means (
|
Analyte |
Weighed-in (mg/L) |
Target* |
(mg/L) |
Returns |
SD |
CV% |
|
Amikacin |
30.0 |
|
26.3 |
92 |
1.6 |
6.2 |
|
Flucytosine |
63.5 |
NS |
61.8 |
8 |
4.4 |
7.1 |
|
Gentamicin |
3.1 |
|
2.9 |
248 |
0.2 |
6.1 |
|
Netilmicin |
7.2 |
NS |
6.9 |
4 |
0.7 |
10.7 |
|
Teicoplanin |
8.9 |
|
9.3 |
23 |
0.9 |
10.2 |
|
Tobramycin |
14.9 |
|
16.5 |
114 |
1.5 |
9.3 |
|
Vancomycin |
6.6 |
|
6.7 |
248 |
0.8 |
11.3 |
|
*NS means the analyte was not scored |
|
|||||
Distribution 2296 closing date
Weighed-in concentrations and
All-laboratory Trimmed Means (
|
Analyte |
Weighed-in (mg/L) |
Target* |
(mg/L) |
Returns |
SD |
CV% |
|
Amikacin |
20.5 |
|
18.4 |
101 |
1.0 |
5.4 |
|
Flucytosine |
36.0 |
NS |
25.4 |
7 |
11.5 |
45.3 |
|
Gentamicin |
12.1 |
|
11.0 |
250 |
1.2 |
10.8 |
|
Netilmicin |
15.8 |
NS |
12.7 |
5 |
4.1 |
32.7 |
|
Teicoplanin |
18.4 |
|
18.3 |
24 |
1.5 |
8.1 |
|
Tobramycin |
4.4 |
|
4.4 |
121 |
0.5 |
10.2 |
|
Vancomycin |
40.0 |
|
40.2 |
255 |
3.8 |
9.3 |
|
*NS means the analyte was not scored |
|
|||||
Distribution 2297 closing date 15-DEC-2008
Weighed-in concentrations and
All-laboratory Trimmed Means (
|
Analyte |
Weighed-in (mg/L) |
Target* |
(mg/L) |
Returns |
SD |
CV% |
|
Amikacin |
4.8 |
|
4.8 |
94 |
0.4 |
8.0 |
|
Flucytosine |
77.0 |
NS |
77.0 |
9 |
9.7 |
14.8 |
|
Gentamicin |
9.2 |
|
9.2 |
243 |
0.6 |
6.8 |
|
Netilmicin |
3.1 |
NS |
3.1 |
4 |
0.5 |
19.9 |
|
Teicoplanin |
58.4 |
|
58.4 |
25 |
4.9 |
8.9 |
|
Tobramycin |
12.4 |
|
12.4 |
114 |
1.2 |
9.7 |
|
Vancomycin |
21.3 |
|
21.3 |
247 |
1.8 |
7.9 |
|
*NS means the analyte was not scored |
|
|||||
Distribution 2298 closing date
Weighed-in concentrations and
All-laboratory Trimmed Means (
|
Analyte |
Weighed-in (mg/L) |
Target* |
(mg/L) |
Returns |
SD |
CV% |
|
Amikacin |
22.0 |
|
19.9 |
98 |
1.2 |
5.9 |
|
Flucytosine |
62.0 |
NS |
62.8 |
7 |
7.7 |
12.3 |
|
Gentamicin |
0.3 |
NS |
0.4 |
197 |
0.1 |
28.2 |
|
Netilmicin |
12.5 |
NS |
14.6 |
5 |
7.3 |
50.2 |
|
Teicoplanin |
30.1 |
|
29.2 |
25 |
1.8 |
6.1 |
|
Tobramycin |
7.6 |
|
7.7 |
122 |
0.7 |
8.6 |
|
Vancomycin |
67.0 |
|
66.5 |
246 |
5.9 |
8.9 |
|
*NS means the analyte was not scored |
|
|||||
Distribution 2299 closing date
Weighed-in concentrations and
All-laboratory Trimmed Means (
|
Analyte |
Weighed-in (mg/L) |
Target* |
(mg/L) |
Returns |
SD |
CV% |
|
Amikacin |
18.0 |
|
17.7 |
100 |
1.0 |
5.9 |
|
Flucytosine |
132.0 |
NS |
121.7 |
8 |
18.9 |
15.6 |
|
Gentamicin |
10.3 |
|
9.5 |
245 |
0.7 |
7.3 |
|
Netilmicin |
9.2 |
NS |
7.9 |
4 |
0.9 |
11.7 |
|
Teicoplanin |
8.4 |
|
8.7 |
26 |
1.0 |
11.8 |
|
Tobramycin |
1.2 |
|
1.2 |
124 |
0.2 |
15.4 |
|
Vancomycin |
13.5 |
|
14.0 |
249 |
1.0 |
7.3 |
|
*NS means the analyte was not scored |
|
|||||
Distribution 2300 closing date
Weighed-in concentrations and
All-laboratory Trimmed Means (
|
Analyte |
Weighed-in (mg/L) |
Target* |
(mg/L) |
Returns |
SD |
CV% |
|
Amikacin |
56.0 |
|
53.9 |
95 |
4.7 |
8.8 |
|
Flucytosine |
48.0 |
NS |
47.4 |
8 |
3.6 |
7.5 |
|
Gentamicin |
5.0 |
|
4.6 |
246 |
0.3 |
6.4 |
|
Netilmicin |
2.1 |
NS |
2.3 |
5 |
0.2 |
6.7 |
|
Teicoplanin |
21.2 |
|
17.8 |
27 |
1.6 |
8.9 |
|
Tobramycin |
11.2 |
|
10.6 |
121 |
1.0 |
9.4 |
|
Vancomycin |
50.0 |
|
49.4 |
243 |
4.5 |
9.1 |
|
*NS means the analyte was not scored |
|
|||||
Weighed-in concentration
The weighed-in concentration (mg/L) is given for information only. It is published three days after the distribution closes and can be used to give a guide to individual laboratory performance. ALTM values (mg/L) and statistics are published as soon as they are available.
Target
The
The weighed-in values are also available by telephone (recorded message) on
INT+